Kamran Hosseini
Directeur Général chez Surface Ophthalmics, Inc.
Postes actifs de Kamran Hosseini
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Directeur Général | - | - |
| President | - | - |
Historique de carrière de Kamran Hosseini
Anciens postes connus de Kamran Hosseini
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALZA CORPORATION | Corporate Officer/Principal | 01/10/2007 | 01/10/2007 |
| INSITE VISION INC. | Directeur Technique/Scientifique/R&D | 01/02/2008 | - |
| Conseiller Juridique Général | 01/02/2008 | - |
Formation de Kamran Hosseini
| University of Groningen | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Pays-Bas | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology InSite Vision Inc. develops and markets ophthalmic pharmaceutical products that designs to treat a range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Its products include AzaSite, Besivance, AzaSite Plus, DexaSite, AzaSite Xtra, and ISV-10 and 303. The company was founded by Merwin Jerry Hansen in 1986 and is headquartered in Alameda, CA. | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Kamran Hosseini
- Expérience
